Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells.
Four human tumor cell lines were grown in direct contact with the extracellular matrix proteins which had previously been produced by cultured rat smooth muscle cells. The extracellular matrix contained glycoproteins, elastin, and collagen, and its digestion by the tumor cells was followed by the appearance of radioactive breakdown products in the supernatant medium. All four tumor lines tested digested glycoproteins present in the matrix, whereas human fibroblasts were inactive in glycoprotein digestion. The human fibrosarcoma cell line (HT1080) demonstrated elastolytic and collagenolytic activity in addition to a plasmin-induced hydrolysis of glycoproteins. Removal of glycoproteins from the matrix was necessary for the maximal digestion rate of elastin and collagen, and plasmin generation by the tumor cell plasminogen activator therefore played a pivotal role in the hydrolysis of all of the matrix components. The elastolytic and collagenolytic activities were localized to the plasma membrane since no matrix digestion occurred unless the tumor cells were grown in direct contact with the connective tissue proteins. These activities were not inhibited by a wide spectrum of protease inhibitors. The degradation of elastin and collagen required active protein synthesis suggesting a relatively short half-life for the degradative enzyme(s). These quantitative studies, in which tumor cells were grown in contact with a complex extracellular matrix possessing some of the characteristics of connective tissue, should have a bearing on tumor cell invasion.
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D003238:Connective Tissue / Q000378:metabolism*; D004549:Elastin / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism*; D005354:Fibrosarcoma / Q000201:enzymology*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D009124:Muscle Proteins / Q000378:metabolism*; D010447:Peptide Hydrolases / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D011480:Protease Inhibitors; D013379:Substrate Specificity
D000964:Antimetabolites, Antineoplastic; D006023:Glycoproteins; D009124:Muscle Proteins; D011480:Protease Inhibitors; D003094:Collagen; D004549:Elastin; D010447:Peptide Hydrolases; D010960:Plasminogen Activators